229 related articles for article (PubMed ID: 23797227)
1. Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation.
Dong A; Wang Y; Dong H; Gong J; Cheng C; Zuo C; Lu J
Clin Nucl Med; 2014 Feb; 39(2):113-21. PubMed ID: 23797227
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
[TBL] [Abstract][Full Text] [Related]
3. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
[TBL] [Abstract][Full Text] [Related]
4. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
5. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
6. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2901-4. PubMed ID: 23328236
[TBL] [Abstract][Full Text] [Related]
8. Malignant nonepithelial prostate tumors: FDG PET/CT findings with MRI and CT correlation.
Dong A; Zhang H; Wang Y; Gong J; Zuo C; Yang J; Lu J
Clin Nucl Med; 2015 Jan; 40(1):14-20. PubMed ID: 24999682
[TBL] [Abstract][Full Text] [Related]
9. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging in differentiating bronchial masses: an initial experience with a combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan.
Kumar A; Jindal T; Dutta R; Kumar R
Ann Nucl Med; 2009 Oct; 23(8):745-51. PubMed ID: 19784877
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location.
Park JM; Kim IY; Kim SW; Lee SM; Kim HG; Kim SY; Shin HC
Ann Nucl Med; 2013 Apr; 27(3):217-24. PubMed ID: 23242953
[TBL] [Abstract][Full Text] [Related]
14. Inferior glucose metabolism and chemosensitivity of post-radiotherapy local recurrence in comparison with distant metastases as assessed by sequential (18)F-FDG PET/CT imaging.
Sun X; Zhao F; Sun L; Li S; Li W; Zhang X; Xing L
Ann Nucl Med; 2014 Aug; 28(7):610-6. PubMed ID: 24838784
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT features of pulmonary sclerosing hemangioma.
Lee E; Park CM; Kang KW; Goo JM; Kim MA; Paeng JC; Lee HJ; Park HS; Chung DH
Acta Radiol; 2013 Feb; 54(1):24-9. PubMed ID: 22291338
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
[TBL] [Abstract][Full Text] [Related]
17. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up using 18F-FDG PET/CT for postoperative olfactory neuroblastoma.
Fujioka T; Toriihara A; Kubota K; Machida Y; Nakamura S; Kishimoto S; Ohashi I; Shibuya H
Nucl Med Commun; 2014 Aug; 35(8):857-63. PubMed ID: 24751700
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of (18)F-FDGPET/CT in differentiation between benign lesions and lung cancer for large shadows in patients with pneumoconiosis].
Wang Y; Zhang H; Cui X; Fang N; Zeng L; Zhang C
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Mar; 32(3):186-9. PubMed ID: 24641846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
